Often, therapeutic development has focused on tiny agents, but peptidic alliances are rapidly demonstrating attention. This novel strategy utilizes combining peptidic sequences with other therapeutic methods to address intricate illness pathways. By employing the distinctive features of peptides – such as significant specificity and delivery –